SCHEMBL19351876

SCHEMBL19351876

CCCP(=O)(ON1C(=O)c2ccccc2C1=O)ON1C(=O)c2ccc(-c3ccc4c(c3)C(=O)N(OP(OC)OC)C4=O)cc2C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPRC P08575 2/20 0.33
▸ BCHE P06276 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ KDM4E B2RXH2 4/20 0.32
▸ MAPT P10636 4/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ F2 P00734 3/20 0.32
▸ VDR P11473 2/20 0.32
▸ PTPN1 P18031 1/20 0.32
▸ MCHR1 Q99705 1/20 0.32
▸ XBP1 P17861 2/20 0.32
▸ HTT P42858 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ DRD3 P35462 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ APAF1 O14727 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ PTBP1 P26599 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19341893 0.80 GAA (0.43) KDM4EMAPTALDH1A1F2VDR
SCHEMBL19341901 0.74 VDR (0.46) KDM4EMAPTALDH1A1F2VDR
SCHEMBL19341897 0.65 GAA (0.50) KDM4EMAPTALDH1A1F2VDR
SCHEMBL19341904 0.61 GAA (0.46) KDM4EMAPTALDH1A1F2VDR
SCHEMBL15086925 0.61 GAA (0.44) KDM4EMAPTALDH1A1F2VDR
SCHEMBL19341908 0.60 GAA (0.48) KDM4EMAPTALDH1A1F2VDR
SCHEMBL19341883 0.59 GAA (0.41) KDM4EMAPTALDH1A1F2VDR
SCHEMBL19341906 0.59 GAA (0.47) KDM4EMAPTALDH1A1F2VDR
SCHEMBL13574906 0.59 KDM4E (0.58) BCHEACHEKDM4EMAPTALDH1A1
SCHEMBL10246381 0.58 KDM4E (0.58) BCHEACHEKDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10544284-B2 Use of phosphorous-containing organic oxyimides as flame retardants and/or as stabilizers for plastics, flame-retardant and/or stabilized plastic compositions, method for the production thereof, moulded part, paint and coatings Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2020-01-28 — — US disclosed
US-20170260366-A1 USE OF PHOSPHOROUS-CONTAINING ORGANIC OXYIMIDES AS FLAME RETARDANTS AND/OR AS STABILIZERS FOR PLASTICS, FLAME-RETARDANT AND/OR STABILIZED PLASTIC COMPOSITIONS, METHOD FOR THE PRODUCTION THEREOF, MOULDED PART, PAINT AND COATINGS Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2017-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170260366-A1 USE OF PHOSPHOROUS-CONTAINING ORGANIC OXYIMIDES AS FLAME RETARDANTS AND/OR AS STABILIZERS FOR PLASTICS, FLAME-RETARDANT AND/OR STABILIZED PLASTIC COMPOSITIONS, METHOD FOR THE PRODUCTION THEREOF, MOULDED PART, PAINT AND COATINGS PFAS, FERMT2, PGM2 PTPRC 1930/4885BCHE 3887/4885ACHE 3203/4885
US-10544284-B2 Use of phosphorous-containing organic oxyimides as flame retardants and/or as stabilizers for plastics, flame-retardant and/or stabilized plastic compositions, method for the production thereof, moulded part, paint and coatings PFAS, FERMT2, PGM2 PTPRC 1930/4885BCHE 3887/4885ACHE 3203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback